Business Wire

SPEECH-PROCESSING

15.10.2020 14:54:07 CEST | Business Wire | Press release

Share
Speech Processing Solutions: Next-generation workflow solution with AI-powered speech recognition

The new version of the Philips dictation workflow solution for enterprise businesses, SpeechExec Enterprise 7.0 (SEE 7.0), is now available in Europe and many international markets. The close collaboration between Nuance Communications and Speech Processing Solutions , the company behind Philips dictation solutions , SEE 7.0 now offers cloud-based Nuance Dragon speech recognition in addition to the workflow, allowing customers to edit or archive both audio and text files.

For speech recognition to meet the requirements of modern work environments and flexible processes in organizations, it must be combined with a workflow solution that tracks status updates and assigns priorities and tasks to dedicated personnel. "This is exactly why customers who use speech technology can benefit greatly from the close cooperation between SPS and Nuance," explains Dr. Thomas Brauner, CEO of Speech Processing Solutions. "As market leaders in our respective fields, we combined the best of both worlds for our customers: speech recognition and workflow solutions."

Ed McGuiggan, General Manager, Dragon Professional, Nuance Communications, adds: "We are pleased to expand our long-lasting partnership with SPS. With the integration of Nuance Dragon into Philips SpeechExec Enterprise 7.0, we created an easy to deploy product that fully meets the requirements of the modern workplace within large enterprise corporations. Together, we are accelerating the adoption and scalability of cloud-based speech recognition solutions to support collaborative work environments, regardless of where employees are located.”

SpeechExec Enterprise 7.0 integrates cloud-based speech recognition

The new version SEE 7.0 now supports state-of-the-art speech recognition technology by utilizing cloud-based Nuance Dragon speech recognition software. The product is available in English, German, French, Dutch, Swedish, and Spanish.

For front-end speech recognition, SpeechExec Enterprise connects to a dedicated Windows server – either on site or in the cloud. This allows authors to take advantage of Nuance's latest speech recognition engine with built-in deep learning technology for their digital dictation workflow. For the back-end speech recognition, files are sent from the Philips Voice Recorder App and mobile dictation devices (Philips SpeechAir, Philips PocketMemo) to a shared network folder. Philips Speech Recognition Server constantly monitors this folder, automatically retrieves new files, and converts them to text.

Companies can use the new solution for a variety of use cases: For e-mails, memos and other short copy, stand-alone speech recognition with Nuance Dragon Legal Anywhere or Nuance Dragon Professional Anywhere is sufficient. Longer copy and comprehensive briefs or contracts involving several people are handled by speech recognition in combination with a dictation workflow. From mobile dictation devices, all texts are processed through speech recognition and then finalized by in-house transcriptionists.

About Speech Processing Solutions

Speech Processing Solutions (SPS) is an international technology company and a global leader in dictation solutions. More than four million users worldwide work with speech-to-text solutions developed by SPS and sold under the Philips brand. These solutions include web-based and desktop workflow software as well as dictation devices. These smart solutions save users’ time and allow them to focus on their core tasks, making their business more efficient, customer-centric and profitable.

Headquartered in Vienna, Austria, SPS has regional offices in the United States, Canada, Australia, the United Kingdom, Germany, France, Belgium and Austria, as well as a network of more than 1000 distribution and implementation partners worldwide.

Link:

ClickThru

Social Media:

http://www.facebook.com/philipsdictation

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents23.4.2026 13:29:00 CEST | Press release

Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agentsA manganese-based MRI contrast agent could address concerns with gadolinium-based contrast agents around retention in the body, security of supply, and the environment, with mangaciclanol’s clinical development under FDA Fast Track designationThe program demonstrates GE HealthCare’s commitment to advancing novel imaging agents to address unmet patient needs GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol, at Mayo Clinic in Rochester, Minnesota. Mangaciclanol, if approved, could offer an alternative to – or even replace – gadolinium-based MRI contrast agents, the current standard of care. The investigational agent has been granted Fast Track designation by t

Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform23.4.2026 13:13:00 CEST | Press release

New structure to drive AI-powered innovation and international expansion Croma Pharma has launched a strategic joint venture to accelerate the development of Clinicore, its premium digital solution for aesthetic practices. This dedicated entity will focus on scaling the next generation of the platform while ensuring full continuity for existing users. Clinicore: Elevating Practice Excellence through AI Clinicore is a specialized SaaS (Software as a Service) solution designed to optimize the daily operations of aesthetic clinics. By automating patient management, scheduling, and administrative workflows, it enables healthcare professionals to focus entirely on patient care. A core element of the new strategy is a strong focus on Artificial Intelligence. Clinicore is evolving into a smart assistant, utilizing AI-driven features for automated treatment documentation, intelligent onboarding tools, and advanced process automation. This ensures that clinics can operate at maximum efficiency

NIQ Launches Commerce Lab to Build the Data and Measurement Layer for AI-Driven Commerce23.4.2026 13:00:00 CEST | Press release

NielsenIQ (NYSE: NIQ) today announced the launch of NIQ Commerce Lab, where the company is building the technology infrastructure for AI-driven commerce. The Lab will develop the data platforms, APIs, and measurement systems that power how products are discovered, evaluated, and purchased in AI-mediated environments. This includes what the industry often refers to as agentic commerce, but extends across quick commerce, social commerce, and other emerging channels—where AI is becoming the common layer shaping how consumers navigate choices and how decisions are made in real time. AI systems are rapidly moving from supporting decisions to making them—playing an increasingly central role in how commerce operates. Their effectiveness depends on the intelligence behind them. AI is Becoming the Operating Layer of Global Commerce NIQ ensures that the intelligence behind these systems is accurate, complete, and grounded in real-world behavior—reflecting how consumers actually buy, what product

Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights23.4.2026 12:10:00 CEST | Press release

Strong FY2025 financial and sustainability results; leadership transition will support continuity and long-term growth Revenue up 8.2% to €3.6bn with double-digit growth in Rare Diseases and U.S. market Air sales at €1.886bn, growing 3.9% vs. 2024 - Care sales at €904m growing 13.3% vs. 2024 - Rare sales at €906m, growing 22.3% vs. 2024 Giuseppe Accogli leaving to pursue another opportunity, Group CFO Jean-Marc Bellemin named Interim CEO while new CEO search is underway Record €885m Research & Development (R&D) investment underscores continued commitment to innovation across respiratory, rare disease and specialty care Sustainability leadership further strengthened through B Corp recertification and progress on Carbon Minimal Inhaler (CMI) innovation Chiesi Group (“Chiesi”), an international research‑focused biopharmaceutical company and certified B Corp, today announced its financial results for the year ended 31 December 2025. Chiesi reported €3.625 billion in consolidated revenues,

REPLY S.p.A.: Shareholders’ Meeting Approves the 2025 Financial Statements23.4.2026 12:05:00 CEST | Press release

Consolidated turnover of €2,483.6 million (€2,300.5 million in 2024);Group net profits of €250.9 million (€211.1 million in 2024).Approval of the proposal to distribute a dividend of €1.35 per share.Approval of the plan for the purchase and/or disposal of treasury shares. The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] held today approved the Financial Statements for the financial year 2025, confirming the distribution of a gross dividend of €1.35 per share. The dividend will be paid on 20 May 2026, with dividend date set on 18 May 2026 (record date on 19 May 2026). Approval of the 2025 financial statements The Reply Group closed the 2025 financial year with a consolidated turnover of €2,483.6 million, recording a 8.0% increase compared to €2,300.5 million in 2024. Consolidated EBITDA was €467.6 million, up 13.9% compared to €410.6 million recorded for the year 2024. EBIT, from January to December, was €397.1 million, up 18.5% compared to €330.4 million recorded for

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye